Publications

KELI Therapeutics is committed to developing revolutionary therapies, from early development to patients.

Within collaborations, we're actively advancing preclinical and clinical research to evaluate our pipeline products and their diverse mechanisms of action.

Cartilage Research:

Mesenchymal Stem Cell Research:

December, 2021

Osteochondral repair and electromechanical evaluation of custom 3D scaffold microstructured by direct laser writing lithography

Cartilage. Thousand Oaks: SAGE Publications

May-August, 2019

Clinical outcome after treatment of single and multiple cartilage defects by autologous matrix-induced chondrogenesis: research article

Journal of Orthopaedic Surgery Hong Kong: Hong Kong University Press

September, 2019

Customization of direct laser lithography-based 3D scaffolds for optimized in vivo outcome

Applied surface science Amsterdam: Elsevier Science

February, 2017

Fabrication of 3D micro-structured scaffolds by direct laser writing in pre-polymers for in vitro and in vivo studies

Frontiers in ultrafast optics: Conference on Frontiers in Ultrafast Optics - Biomedical, Scientific, and Industrial Applications XVII

November, 2016

Characterization of tissue engineered cartilage products: recent developments in advanced therapy

Pharmacological research London: Elsevier

April, 2016

Clinical outcome after treatment of characterised cartilage defects by autologous matrix-induced chondrogenesis in active patients

Osteoarthritis and Cartilage / OARS

March, 2015

Preclinical study of SZ2080 material 3D microstructured scaffolds for cartilage tissue engineering made by femtosecond direct laser writing lithography

Biofabrication. Bristol

October, 2022

Methods and criteria for validating the multimodal functions of perinatal derivatives when used in oncological and antimicrobial applications

Frontiers in Bioengineering and Biotechnology

April, 2022

Placental Stem Cells Efficacy in a Preclinical Kidney Injury Model

Tissue engineering: Part A: 6th World Congress TERMIS

December, 2020

Perinatal stem cells efficacy in the management of preclinical acute kidney injury

XV Baltic Nephrology Conference “UpToDate in Nephrology, Dialysis and Kidney Transplantation”

May, 2020

Placenta derived stem cells for acute kidney injury treatment in a xenogeneic preclinical model

Cytotherapy: ISCT 2020 Annual Meeting Paris Virtual

June, 2016

Comparison of muscle-derived stem/ progenitor cells and bone marrow mesenchymal stem cells for the treatment of acute kidney injury

Acta Physiologica : FEPS 2016 - Joint meeting of the Federation of European physiological societies and the French physiological society

March, 2016

Skeletal muscle-derived stem/progenitor cells: A potential strategy for the treatment of acute kidney injury

Stem cells international. New York: Hindawi Publishing Corpo ration

November, 2015

Skeletal muscle-derived stem/progenitor cells: a potential strategy for the treatment of acute kidney injury

The 6th International Pharmaceutical Conference "Science and Practice 2015": book of abstracts

July, 2013

Development of experimental nephrotoxicity model in vivo and assessment of its' applicability for stem cell research

10th EACPT Summer School 2013, Edinburgh